EUCTR2004-000379-32-IT进行中（未招募）不适用
A Randomized, Partially Blinded, Phase II Study to Assess the Safety, Tolerability, and Efficacy of ZD6474 Alone or in Combination with Paclitaxel and Carboplatin in Subjects with Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- ASTRAZENECA
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A Randomized, Partially Blinded, Phase II Study to Assess the Safety, Tolerability, and Efficacy of ZD6474 Alone or in Combination with Paclitaxel and Carboplatin in Subjects with Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) - 6474IL0007on Small Cell Lung CancerEUCTR2004-000379-32-FIAstraZeneca AB200
进行中（未招募）
1 期
A Randomized, Partially Blinded, Phase II Study to Assess the Safety, Tolerability, and Efficacy of ZD6474 Alone or in Combination with Paclitaxel and Carboplatin in Subjects with Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLCnon small cell lung cancerEUCTR2004-000379-32-ESAstraZeneca AB200
招募中
1 期
MENACWY=MEN7B-003Infections, MeningococcalMedDRA version: 20.0Level: PTClassification code: 10027249Term: Meningitis meningococcal Class: 100000004862CTIS2023-506449-40-00GlaxoSmithKline Biologicals703
进行中（未招募）
1 期
A study on the safety, tolerability and immune response of meningococcal combined ABCWY vaccine in healthy infants.EUCTR2021-001367-24-FIGlaxoSmithKline Biologicals SA688
进行中（未招募）
1 期
A study on the safety, tolerability and immune response of meningococcal combined ABCWY vaccine in healthy infants.Healthy volunteers (Active immunization against IMD caused by Neisseria Meningitidis (N.meningitidis) serogroups A, B, C, W and Y)MedDRA version: 20.0Level: PTClassification code 10027249Term: Meningitis meningococcalSystem Organ Class: 10021881 - Infections and infestationsEUCTR2021-001367-24-ESGlaxoSmithKline SA688